Women’s health startup Natalist makes doctor-approved fertility and pregnancy essentials with a net-zero plastic footprint. Today the company announced an expansion to nearly 6,000 retail locations nationwide. Following a successful initial launch in select Target stores in March 2020, Natalist’s 2021 retail expansion includes a much larger footprint in Target stores across the US plus rollouts in Rite Aid, Albertsons, Safeway, and Shaw’s.…
Organon, a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding. Postpartum hemorrhage is one of the most common complications of birth, requiring pharmacologic treatment in up to 10% of mothers and potentially resulting in…
Merck, known as MSD outside the United States and Canada, announced today the creation of the Kenneth C. Frazier Award for Maternal Health Equity, a grant award that will be bestowed annually to one organization in recognition of its commitment to and progress toward more equitable, high-quality maternal health care. The award will be granted by Merck for Mothers, Merck’s global initiative…
Raydiant Oximetry has received a $3M grant from the government of Ireland. The company now plans to build a team in Ireland. As C-sections continue to rise worldwide, more mothers and babies are at risk from perinatal complications. Raydiant Oximetry, a Fogarty Innovation graduate, is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth and recently received a…
Kindbody today announced the launch of Kindbody360, a dynamic and integrative solution focused on holistic care. Kindbody360 deftly augments Kindbody’s fertility and family-building offering with mental, physical, and emotional support from pre to postpartum, in-clinic, online and via its telehealth platform. Leveraging proprietary technology, the offering expands the reach of the company’s brick-and-mortar locations, mobile pop-ups, and 300+ partner clinics, furthering its…
U.S. based femtech startup LiquidGoldConcept announced it has been awarded an additional $55,000 in National Institutes of Health (NIH) funding in support of its Lactation Simulation Models (LSM) and Newborn Oral Assessment and Latch Simulators (NORALSim). The new grant is in addition to $250,000 in NIH support the company received in July of 2020 for its breastfeeding training technology. The $55,000 grant is through the National Centers for Clinical and Translational Science (NCATS), a…
Sera Prognostics, “The Pregnancy Company”, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the completion of a $100 million Series E financing. Several leading healthcare-focused institutional investors have joined this financing round, including Vivo Capital, aMoon Fund, Parian Global, and others, led by existing investors Anthem, Inc., and Blue Ox Healthcare…
Earlier today Mirvie announced it is making rapid progress toward developing a simple, personalized blood test with the potential for early detection of pregnancy complications, such as preterm birth, preeclampsia and gestational diabetes, which affect 1 in 5 women. Currently, there is no reliable way to identify if a mother is at risk for these significant pregnancy complications. Pregnancy complications, such as…
